We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Advisors Urge Approval of First Preoperative Breast Cancer Treatment
FDA Advisors Urge Approval of First Preoperative Breast Cancer Treatment
September 13, 2013
FDA advisors Sept. 12 delivered a resounding recommendation for swift approval of Genentech’s sBLA for Perjeta as the first sanctioned preoperative breast cancer therapy.